Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction
LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future…
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the…
AvePoint Announces Dual Listing on the Singapore Exchange to Continue Global Expansion
JERSEY CITY, N.J., Sept. 18, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT,…
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering
September 18, 2025 21:26 ET | Source: Reviva Pharmaceuticals CUPERTINO, Calif., Sept.…
89bio, Inc. Announces Agreement to be Acquired by Roche
September 18, 2025 01:02 ET | Source: 89bio, Inc. – 89bio stockholders…
The Global Citizen Hub Announces Launch of European Scholarship Database for International Students
Austin, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Global Citizen Hub…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
GIGABYTE Announces the Availability of its AI-enhanced AORUS X870E X3D Series Motherboards for AMD Ryzen X3D Processors
TAIPEI, Sept. 17, 2025 /PRNewswire/ -- GIGABYTE, the world's leading computer brand,…
LCM Partners Announces 3.8 Billion First Close of Credit Opportunities 5 Strategy
LONDON, Sept. 16, 2025 /PRNewswire/ -- LCM Partners, one of Europe's leading…
